Table 3.
Baseline Pre NDI | Baseline Post NDI | Change in Baseline | p- value | 3 Week | 3 Week Change | p-value | |
---|---|---|---|---|---|---|---|
Clinical Pain | 51.3 (28.7) | NA | NA | NA | 37.9 (29.5) | −13.4 (31.2) | 0.08 |
MP Brachioradialis | 30.8 (26.7) | 26.5 (29.4) | −4.3 (18.2) | 0.32 | 23.9 (25.5) | −6.9 (16.4) | 0.14 |
MP Flexor Retinaculum | 14.0 (20.9) | 14.5 (21.2) | 0.05 (13.5) | 0.87 | 8.1(13.8) | −5.9 (17.6) | 0.09 |
Temporal Summation | 8.1 (19.0) | 1.2 (13.4) | −6.9 (23.9) | 0.21 | 2.5 (16.0) | −5.6 (21.4) | 0.23 |
After-sensation | 25.4 (21.2) | 22.9 (26.1) | −2.5(16.9) | 0.62 | 30.2 (31.5) | 4.8 (24.8) | 0.43 |
Immediate and 3- week changes in pain sensitivity and clinical pain intensity in response to a neurodynamic intervention (NDI). MP= mechanical pain sensitivity to 2.3 kg of force as indicated along a 100 mm mechanical visual analog scale (mvas). Clinical pain, temporal summation, and after- sensation were all measured by a 0 to 100 numeric rating scale anchored with 0= no pain to 100= the worst pain imaginable.